Zeo ScientifiX, Inc. (ZEOX)
ZEOX is quoted over the counter, not listed on an exchange. Zeo ScientifiX, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | ZEOX, quoted over the counter |
| SEC CIK | 0001557376 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Business address | Davie, FL |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Based on the foregoing conditions and uncertainties, management has concluded that substantial doubt exists regarding the Company's ability to continue as a going concern for the twelve months following the issuance of these consolidated financial statements." | 10-KT 2026-10-13 |
| Cash and burn | $1.8M cash; operating cash flow -$312K a quarter. | Report 2026-04-30 |
| Shares outstanding | 7,837,441 (2026-10-12); 6,551,094 a year earlier; 1,456,696,392 three years earlier. 3y figure adjusted for split (1-for-200 overall). | Cover page 2026-10-12 |
| Reverse splits, 3 years | 1; latest 1-for-200 on 2023-11-28 | Source 2023-11-28 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Weinberg & Company, P.A., Los Angeles, California, United States | PCAOB Form AP 2026-10-19 |
| Late filings, 12 months | 2 NT notices | NT 10-K 2026-09-28 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-04-30 | $2.6M | -$145K | -$138K | $1.8M | $247K | $7.0M | 10-Q 2026-06-15 |
| Q1 2026 2026-01-31 | $1.4M | -$852K | -$471K | $1.0M | $245K | $5.6M | 10-Q 2026-03-17 |
| Q4 2025 2025-10-31 | $1.7M | -$815K | -$383K | $221K | $243K | $5.2M | 10-KT 2026-10-13 |
| Q3 2025 2025-07-31 | $1.3M | -$2.1M | -$257K | $314K | $698K | $4.8M | 10-Q 2025-09-15 |
| Q2 2025 2025-04-30 | $1.1M | -$1.4M | -$143K | $542K | $692K | $4.6M | 10-Q 2026-06-15 |
| Q1 2025 2025-01-31 | $1.1M | -$1.2M | $65K | $720K | $686K | $4.6M | 10-Q 2026-03-17 |
| Q4 2024 2024-10-31 | $1.2M | -$1.3M | -$366K | $657K | $680K | $4.6M | 10-KT 2026-10-13 |
| Q3 2024 2024-07-31 | $1.1M | -$1.0M | -$94K | $1.1M | $51K | $4.8M | 10-Q 2025-09-15 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2025-05-16 |
| Latest annual report | 10-KT | 2026-10-13 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-11-03 |
Source: SEC EDGAR submissions feed, 519 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier